Why the study?
Does brain SPECT with 99mTc-HMPAO correlate with cognitive function in patients with metabolic syndrome undergoing antihypertensive therapy?
Does brain SPECT with 99mTc-HMPAO correlate with cognitive function in patients with metabolic syndrome undergoing antihypertensive therapy?
Brain SPECT with 99mTc-HMPAO can diagnose diffuse cerebral circulation disorders that correlate with cognitive dysfunction in patients with metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Cohort data link cerebral perfusion to cognition in metabolic syndrome; leaves open whether SPECT refines antihypertensive decisions.
The purpose of this study is to investigate the potential of brain tomoscintigraphy with 99m Tc-HMPAO in the evaluation of cerebral blood flow in the patients with metabolic syndrome (MS), as well as the study of the relationship of brain perfusion and cognitive function. The study included 54 patients with MS who have undergone perfusion single-photon emission tomography (SPECT) of the brain and neuropsychological testing before and after antihypertensive therapy. Thus, brain SPECT with 99m Tc-HMPAO in the patients with MS provides an opportunity to diagnose diffuse disorders of cerebral circulation in the different regions of the brain, leading to cognitive dysfunction in these patients. Close relationship between the parameters of cerebral perfusion and cognitive performance status of the patients was identified.
No takes yet. Share an insight, caveat, or question.
Efimova et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: